These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 30952479)

  • 1. Risk stratification of non-alcoholic fatty liver disease across body mass index in a community basis.
    Huang JF; Tsai PC; Yeh ML; Huang CF; Huang CI; Hsieh MH; Dai CY; Yang JF; Chen SC; Yu ML; Chuang WL; Chang WY
    J Formos Med Assoc; 2020 Jan; 119(1 Pt 1):89-96. PubMed ID: 30952479
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lean-non-alcoholic fatty liver disease increases risk for metabolic disorders in a normal weight Chinese population.
    Feng RN; Du SS; Wang C; Li YC; Liu LY; Guo FC; Sun CH
    World J Gastroenterol; 2014 Dec; 20(47):17932-40. PubMed ID: 25548491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Obesity and metabolic syndrome as risk factors for the development of non-alcoholic fatty liver disease as diagnosed by ultrasound.
    Petrović G; Bjelaković G; Benedeto-Stojanov D; Nagorni A; Brzački V; Marković-Živković B
    Vojnosanit Pregl; 2016 Oct; 73(10):910-20. PubMed ID: 29327896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors and metabolic abnormality of patients with non-alcoholic fatty liver disease: Either non-obese or obese Chinese population.
    Lee SW; Lee TY; Yang SS; Tung CF; Yeh HZ; Chang CS
    Hepatobiliary Pancreat Dis Int; 2018 Feb; 17(1):45-48. PubMed ID: 29428103
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Characteristics and Metabolic Profiles of Non-Alcoholic Fatty Liver Disease (NAFLD) in Lean Patients and Their Comparison with Obese and Overweight NAFLD.
    Chakrabarty M; Jha AN; Sharma DJ
    J Assoc Physicians India; 2022 Apr; 70(4):11-12. PubMed ID: 35443531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systematic review with meta-analysis: risk factors for non-alcoholic fatty liver disease suggest a shared altered metabolic and cardiovascular profile between lean and obese patients.
    Sookoian S; Pirola CJ
    Aliment Pharmacol Ther; 2017 Jul; 46(2):85-95. PubMed ID: 28464369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nonalcoholic fatty liver disease as a sentinel marker for the development of diabetes mellitus in non-obese subjects.
    Kim SS; Cho HJ; Kim HJ; Kang DR; Berry JR; Kim JH; Yang MJ; Lim SG; Kim S; Cheong JY; Cho SW
    Dig Liver Dis; 2018 Apr; 50(4):370-377. PubMed ID: 29398414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of Non-alcoholic Fatty Liver Disease with Metabolic Syndrome Independently of Central Obesity and Insulin Resistance.
    Yang KC; Hung HF; Lu CW; Chang HH; Lee LT; Huang KC
    Sci Rep; 2016 Jun; 6():27034. PubMed ID: 27246655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between obesity, metabolic syndrome, and nonalcoholic fatty liver disease in the elderly agricultural and fishing population of Taiwan.
    Shen HC; Zhao ZH; Hu YC; Chen YF; Tung TH
    Clin Interv Aging; 2014; 9():501-8. PubMed ID: 24741297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liver and Cardiovascular Damage in Patients With Lean Nonalcoholic Fatty Liver Disease, and Association With Visceral Obesity.
    Fracanzani AL; Petta S; Lombardi R; Pisano G; Russello M; Consonni D; Di Marco V; Cammà C; Mensi L; Dongiovanni P; Valenti L; Craxì A; Fargion S
    Clin Gastroenterol Hepatol; 2017 Oct; 15(10):1604-1611.e1. PubMed ID: 28554682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of Lean Patients with Non-alcoholic Fatty Liver Disease in a Middle Income Country; Prevalence and Its Association with Metabolic Disorders: A Cross-sectional Study.
    Naderian M; Kolahdoozan S; Sharifi AS; Garmaroudi G; Yaseri M; Poustchi H; Sohrabpour AA
    Arch Iran Med; 2017 Apr; 20(4):211-217. PubMed ID: 28412824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic syndrome is not uncommon among lean non-alcoholic fatty liver disease patients as compared with those with obesity.
    Sinha N; Mukhopadhyay S; Sau M
    Indian J Gastroenterol; 2020 Feb; 39(1):75-83. PubMed ID: 32314167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of effects of obesity and non-alcoholic fatty liver disease on incidence of type 2 diabetes mellitus.
    Li WD; Fu KF; Li GM; Lian YS; Ren AM; Chen YJ; Xia JR
    World J Gastroenterol; 2015 Aug; 21(32):9607-13. PubMed ID: 26327768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Analysis of influencing factors and causes of death in elderly residents with non-alcoholic fatty liver disease].
    Xu JY; Shao Y; Lu XL; Deng J; Li XL; Shi HT
    Zhonghua Gan Zang Bing Za Zhi; 2019 Mar; 27(3):204-209. PubMed ID: 30929337
    [No Abstract]   [Full Text] [Related]  

  • 15. Global prevalence, incidence, and outcomes of non-obese or lean non-alcoholic fatty liver disease: a systematic review and meta-analysis.
    Ye Q; Zou B; Yeo YH; Li J; Huang DQ; Wu Y; Yang H; Liu C; Kam LY; Tan XXE; Chien N; Trinh S; Henry L; Stave CD; Hosaka T; Cheung RC; Nguyen MH
    Lancet Gastroenterol Hepatol; 2020 Aug; 5(8):739-752. PubMed ID: 32413340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin resistance and metabolic syndrome in nonobese Indian patients with non-alcoholic fatty liver disease.
    Bhat G; Baba CS; Pandey A; Kumari N; Choudhuri G
    Trop Gastroenterol; 2013; 34(1):18-24. PubMed ID: 23923370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolically healthy and unhealthy obesity phenotypes in the general population: the FIN-D2D Survey.
    Pajunen P; Kotronen A; Korpi-Hyövälti E; Keinänen-Kiukaanniemi S; Oksa H; Niskanen L; Saaristo T; Saltevo JT; Sundvall J; Vanhala M; Uusitupa M; Peltonen M
    BMC Public Health; 2011 Oct; 11():754. PubMed ID: 21962038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non alcoholic fatty liver disease and risk of incident diabetes in subjects who are not obese.
    Sung KC; Seo DC; Lee SJ; Lee MY; Wild SH; Byrne CD
    Nutr Metab Cardiovasc Dis; 2019 May; 29(5):489-495. PubMed ID: 30940491
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of biopsy-proven non-alcoholic fatty liver disease in severely obese subjects without metabolic syndrome.
    Qureshi K; Abrams GA
    Clin Obes; 2016 Apr; 6(2):117-23. PubMed ID: 26856683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonalcoholic Fatty Liver Disease in Lean Subjects: Associations With Metabolic Dysregulation and Cardiovascular Risk-A Single-Center Cross-Sectional Study.
    Semmler G; Wernly S; Bachmayer S; Wernly B; Schwenoha L; Huber-Schönauer U; Stickel F; Niederseer D; Aigner E; Datz C
    Clin Transl Gastroenterol; 2021 Apr; 12(4):e00326. PubMed ID: 33821832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.